Table 2.

Summary of studies involving fecal microbiota transplantation and inflammatory bowel disease

Author, year	Method	Mode of FMT Delivery	n	Outcome
Borody et al., 1989 [38]	Case series	Not reported	2	Positive
Borody et al., 2003 [39]	Case series	Enema	6	Clinical & endoscopic remission at 1 year
Angelberger et al., 2013 [50]	Cohort study	Nasojejunal infusion & enema	5	Positive
Kump et al., 2013 [51]	Cohort study	Colonoscopy	6	Positive
Kunde et al., 2013 [52]	Cohort study	Enema	10	33% clinical response at 1 month
Danman et al., 2014 [53]	Cohort study	Colonoscopy	5	20% clinical response
Cui et al., 2015 [47]	Cohort study	Nasogastric infusion	14	57% clinical improvement
Cui et al., 2015 [49]	Cohort study	Nasogastric infusion	30	86.6% clinical remission at 30 days
Moayyedi et al., 2015 [39]	RCT	Enema	65	24% achieved remission
Rossen et al., 2015 [78]	RCT	Autologous stool	48	No significant effect
Suskind et al., 2015 [46]	Cohort study	Nasogastric infusion	9	78% clinical remission
Wei et al., 2015 [54]	Cohort study	Colonoscopy (ulcerative colitis), nasojejunal infusion	14	Clinical improvement
		(Crohn’s disease)
Paramsothy et al., 2016 [43]	RCT	Enema	81	30% remission achieved
Uygun et al., 2017 [48]	Cohort study	Colonoscopy	30	70% improved symptoms, 43.3% clinical&endoscopic remission

FMT: Fecal microbiota transplantation; RCT: Randomized controlled trial.